Abbott Laboratories buy Citigroup Inc.
Start price
25.01.24
/
50%
€102.48
Target price
25.01.25
€116.25
Performance (%)
-5.72%
Price
14:58
€96.10
Summary
This prediction is currently active. With a performance of -5.72%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. A total of €0.52 was paid as dividends for this prediction. This prediction currently runs until 25.01.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | -1.587% | -1.587% |
iShares Core DAX® | 1.851% | 5.158% |
iShares Nasdaq 100 | 1.573% | 2.589% |
iShares Nikkei 225® | -0.412% | -2.857% |
iShares S&P 500 | 1.128% | 2.485% |
Comments by Citigroup_Inc_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Citigroup Inc. from $123.00 to $126.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.10
03.04.24
03.04.24
€118.21
03.04.25
03.04.25
-6.40%
14:58
14:58